Refractory Anemia With Excess Blasts-1 (5-10% Blasts)
1 clinical trials · Condition
◉ Watch Refractory Anemia With Excess Blasts-1 (5-10% Blasts)
| Record | Firm | Date |
|---|---|---|
| Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT (NCT01012492) | Boston Children's Hospital | 2009-11-01 |
Track Refractory Anemia With Excess Blasts-1 (5-10% Blasts) automatically
Every clearance here is in the API, with alerts when new ones post.